COMPANY OVERVIEW

OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria.

---

LOCATION

Stockholm, , Europe

---

THERAPEUTIC AREAS

Rare Diseases

---

WEBSITE

https://www.oxthera.com/

---

CAREER WEBSITE

https://www.oxthera.com/career/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jun 11, 2021

OxThera reports results from Phase 3 ePHex study with Oxabact in primary hyperoxaluria patients with maintained kidney function

Apr 6, 2020

OxThera Announces Completion of Recruitment in Phase 3 ePHex Study With Oxabact in Patients With Primary Hyperoxaluria

Nov 7, 2019

OxThera Presents Full 24-month Data for Oxabact in Primary Hyperoxaluria Type 1 (PH1) Patients With ESRD at Kidney Week 2019 USA - English USA - Français USA - Deutsch USA - español

Nov 7, 2019

OxThera présente les données complètes sur 24 mois d'un traitement à base d'Oxabact pour des patients souffrant d'hyperoxalurie primaire de Type 1 (HP1) avec IRPT dans le cadre de la Semaine du rein 2019 France - Français USA - English Deutschland - Deutsch España - español

Nov 7, 2019

OxThera presenta datos para Oxabact en pacientes con HP1 España - español USA - English France - Français Deutschland - Deutsch

For More Press Releases

---